FDA advisory panel votes against new use of AbbVie's Humira
(Reuters) - An advisory panel to the U.S. Food and Drug Administration voted against approving AbbVie Inc's rheumatoid arthritis drug Humira for treat...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/SbhbtipeUxs/story01.htm
No comments:
Post a Comment